Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients. Read the full articles: https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00284-2/fulltext?dgcid=buzzsprout_icw ... Show More
Jul 30
Metformin as an adjunctive therapy to an intensive lifestyle intervention in older adults with obesity with Dennis Villareal
Metformin has received a lot of attention in the field of ageing, though clinical trials remain scarce. Dennis Villareal (Michael E. DeBakey VA Medical Center, Houston, USA) discusses the DEMFOS trial assessingl assessing whether adding metformin to an intensive lifestyle interve ... Show More
13m 44s
Jul 2023
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Guideline Update
Dr. Supriya Mohile , Dr. William Dale, and Dr. Heidi Klepin discuss the updated guideline on the practical assessment and management of age-associated vulnerabilities in older patients undergoing systemic cancer therapy. They highlight recent evidence that prompted the guideline ... Show More
23m 9s
Oct 2025
Ep. 245 Understanding Keynote-689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden, Dr. Ravi Uppaluri and Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing clinicians to rethink their entire workflow, starting with diagnosis. In this episode of the BackTable Podcast, head and neck surgica ... Show More
40m 45s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multicom ... Show More
24m 12s
Jun 2025
Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer
Interview with Leila J. Mady, MD, PhD, MPH, author of Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer
14m 15s
Apr 2024
Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer
Interview with Evan M. Graboyes, MD, MPH, author of Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer
19m 56s
Nov 2023
Low carb and cancer screening
<p>Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research. </p>
<p> </p>
<p>In this episode:</p>
<p>Helen Macdona ... Show More
33m 22s
Mar 2023
Curing cancer, from bench to bedside
Medical research sits at the intersection of the lab and the clinic. It's critical for translating breakthrough science into possible treatments for people. It's most successful when scientists and clinicians collaborate. Today, we're talking with Professor Anthony Joshua, one of ... Show More
22m 5s
Dec 2024
Inside Health: How can we age well?
From the Hay Festival, James and a panel of experts explain what we can all do to help ourselves age well.We discover what’s going on in our bodies when we age, the difference between biological and chronological age, as well as getting the audience moving for a physical test.Jam ... Show More
26m 28s
Aug 2025
Geriatric Assessment Global Guideline
Dr. Cris Bergerot and Dr. Enrique Soto join the podcast to discuss the new global guideline on geriatric assessment. This guideline provides evidence-based, resource-stratified recommendations across the basic, limited, and enhanced settings. Dr. Bergerot and Dr. Soto discuss who ... Show More
16m 19s